Gilead’s next step on coronavirus: inhaled remdesivir, other easier-to-use versions

© Reuters. FILE PHOTO: A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California By Deena Beasley (Reuters) – Gilead Sciences Inc (O:) is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones that can be inhaled, after trials showed […]

Continue Reading